Dipna Pharmachem [DPL] vs Trident Lifeline [TLL] Detailed Stock Comparison

Dipna Pharmachem Ltd.

BSE
Loading...

Trident Lifeline Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dipna Pharmachem Ltd. wins in 8 metrics, Trident Lifeline Ltd. wins in 10 metrics, with 0 ties. Trident Lifeline Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dipna Pharmachem Ltd. Trident Lifeline Ltd. Better
P/E Ratio (TTM) 10.09 19.65 Dipna Pharmachem Ltd.
Price-to-Book Ratio 0.35 3.50 Dipna Pharmachem Ltd.
Debt-to-Equity Ratio 23.42 68.64 Dipna Pharmachem Ltd.
PEG Ratio N/A 0.33 N/A
EV/EBITDA 8.55 16.03 Dipna Pharmachem Ltd.
Profit Margin (TTM) 1.92% 12.58% Trident Lifeline Ltd.
Operating Margin (TTM) 2.34% 10.24% Trident Lifeline Ltd.
EBITDA Margin (TTM) 2.34% 10.24% Trident Lifeline Ltd.
Return on Equity 4.24% 16.87% Trident Lifeline Ltd.
Return on Assets (TTM) 1.59% 7.53% Trident Lifeline Ltd.
Free Cash Flow (TTM) $-92.15M $-213.41M Dipna Pharmachem Ltd.
Dividend Yield 23.16% N/A N/A
1-Year Return -67.35% -9.90% Trident Lifeline Ltd.
Price-to-Sales Ratio (TTM) 0.21 2.30 Dipna Pharmachem Ltd.
Enterprise Value $338.55M $3.47B Trident Lifeline Ltd.
EV/Revenue Ratio 0.32 2.74 Dipna Pharmachem Ltd.
Gross Profit Margin (TTM) 44.45% 42.11% Dipna Pharmachem Ltd.
Revenue per Share (TTM) $45 $110 Trident Lifeline Ltd.
Earnings per Share (Diluted) $0.86 $12.44 Trident Lifeline Ltd.
Beta (Stock Volatility) -0.17 -0.20 Trident Lifeline Ltd.

Dipna Pharmachem Ltd. vs Trident Lifeline Ltd. Stock Performance Analysis

Loading Price Chart...

DPL
TLL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dipna Pharmachem Ltd.-2.37%-6.80%-16.79%-13.28%-58.32%-59.48%
Trident Lifeline Ltd.-0.84%-2.08%-2.70%-8.73%-21.79%-23.32%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dipna Pharmachem Ltd.-67.35%-96.95%-96.44%-90.95%-93.55%-93.55%
Trident Lifeline Ltd.-9.90%70.60%147.03%147.03%147.03%147.03%

Performance & Financial Health Analysis: Dipna Pharmachem Ltd. vs Trident Lifeline Ltd.

MetricDPLTLL
Market Information
Market Cap i₹228.19M₹3.01B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i45,90031,800
90 Day Avg. Volume i51,20047,540
Last Close₹6.99₹242.55
52 Week Range₹6.66 - ₹25.66₹229.95 - ₹328.00
% from 52W High-72.76%-26.05%
All-Time High₹558.00 (Jan 29, 2024)₹339.00 (Sep 02, 2024)
% from All-Time High-98.75%-28.45%
Growth Metrics
Quarterly Revenue Growth-0.20%1.17%
Quarterly Earnings Growth3.19%0.54%
Financial Health
Profit Margin (TTM) i0.02%0.13%
Operating Margin (TTM) i0.02%0.10%
Return on Equity (TTM) i0.04%0.17%
Debt to Equity (MRQ) i23.4268.64
Cash & Liquidity
Book Value per Share (MRQ)₹24.62₹69.84
Cash per Share (MRQ)₹0.29₹2.27
Operating Cash Flow (TTM) i₹-140,640,000₹-171,590,000
Levered Free Cash Flow (TTM) i₹-160,558,752₹117.48M
Dividends
Last 12-Month Dividend Yield i23.16%N/A
Last 12-Month Dividend i₹5.00N/A

Valuation & Enterprise Metrics Analysis: Dipna Pharmachem Ltd. vs Trident Lifeline Ltd.

MetricDPL (Apr 26, 2026)TLL (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i10.0919.65
Forward P/E iN/AN/A
PEG Ratio iN/A0.33
Price to Sales (TTM) i0.212.30
Price to Book (MRQ) i0.353.50
Market Capitalization
Market Capitalization i₹228.19M₹3.01B
Enterprise Value i₹338.55M₹3.47B
Enterprise Value Metrics
Enterprise to Revenue i0.322.74
Enterprise to EBITDA i8.5516.03
Risk & Other Metrics
Beta i-0.17-0.20
Book Value per Share (MRQ) i₹24.62₹69.84

Financial Statements Comparison: Dipna Pharmachem Ltd. vs Trident Lifeline Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDPL (2025)TLL (2025)
Revenue/Sales i1.25B869.65M
Cost of Goods Sold i1.14B519.64M
COGS % of Revenue i91.0%59.8%
Gross Profit i111.90M350.01M
Gross Margin i9.0%40.2%
Research & Development iN/A4.86M
Operating Income (EBIT) i40.07M114.86M
Operating Margin i3.2%13.2%
EBITDA i38.19M187.97M
EBITDA Margin i3.1%21.6%
Pre-Tax Income i14.20M136.15M
Pre-Tax Income % of Revenue i1.1%15.7%
Income Tax i4.47M31.20M
Income Tax % of Revenue i0.4%3.6%
Net Income (Profit) i9.73M104.95M
Profit Margin i0.8%12.1%

Balance Sheet & Liquidity Metrics

MetricDPL (2025)TLL (2025)
Cash & Equivalents i4.26M24.61M
Total Current Assets i1.32B903.71M
Total Current Assets % of Revenue i105.9%103.9%
Total Current Liabilities i849.96M535.55M
Total Current Liabilities % of Revenue i68.0%61.6%
Long-Term Debt i88.90M322.73M
Long-Term Debt % of Revenue i7.1%37.1%
Total Shareholders Equity i384.93M696.50M
Retained Earnings i31.22M211.15M
Retained Earnings % of Revenue i2.5%24.3%
Property, Plant & Equipment i489,00062.95M

Cash Flow Statement Comparison

MetricDPL (2025)TLL (2025)
Operating Cash Flow i-92.83M-171.59M
Operating Cash Flow % of Revenue i-7.4%-19.7%
Capital Expenditures i-201,000-111.00M
Free Cash Flow i-92.15M-213.41M
FCF Margin i-7.4%-24.5%
Debt Repayment i-36.57MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDPLTLL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i24.05M11.59M
Float Shares i11.37M3.93M
% Held by Insiders i51.68%77.28%
% Held by Institutions i0.00%0.00%
% Held by Public i48.32%22.72%

Dividend Analysis & Yield Comparison: Dipna Pharmachem Ltd. vs Trident Lifeline Ltd.

MetricDPLTLL
Last 12-Month Dividend i₹5.00N/A
Last 12-Month Dividend Yield i23.16%N/A
3-Year Avg Annual Dividend i₹6.00N/A
3-Year Avg Dividend Yield i1.72%N/A
3-Year Total Dividends i₹18.00N/A
Ex-Dividend DateAug 13, 2024N/A